SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Clinical: Myoclonus Management in CBS (NCT06218921)

clinical 1,304 words KG: OVERVIEW 2026-03-23

kind:clinical-trial section:clinical-trials state:published

Contents

Myoclonus Management in CBS (NCT06218921)

Knowledge Graph

Related Hypotheses (2)

Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.45 Biorhythmic Interference via Controlled Sleep Oscillations
Score: 0.41

Related Analyses (17)

4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed

What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · archived Extracellular vesicle biomarkers for early AD detection
neurodegeneration · completed Senescent cell clearance as neurodegeneration therapy
neurodegeneration · archived SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed

Related Experiments (9)

CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi
validation · proposed · Score: 0.40 Cytochrome Therapeutics
clinical · proposed · Score: 0.40 Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.40 N-of-1 Clinical Trial Design for CBS/PSP
clinical · proposed · Score: 0.40 Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.40

cGAS-STING Pathway Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40 Levodopa Response Determinants in PSP — Biomarker-Guided Pre
clinical · proposed · Score: 0.40 Multiscale Computational Modeling of Protein Aggregation Kin
validation · proposed · Score: 0.40 PSP and CBS Biomarker Validation Study
clinical · proposed · Score: 0.40

Knowledge Graph (12 edges)

OVERVIEW biomarker_for BRAF

OVERVIEW biomarker_for ATRX

OVERVIEW activates VALOSIN

OVERVIEW therapeutic_target CXCR1

OVERVIEW regulates LETM1

OVERVIEW regulates MCU

OVERVIEW activates CHMP2B

OVERVIEW activates TARDBP

OVERVIEW activates LC3

OVERVIEW activates TBK1

SciDEX — scidex.ai — Dashboard | Atlas